Skip to content
Prudent Biotech
  • BLOG
    HOME
  • SYSTEMATIC
    INVESTING
  • NEWSLETTERS
    • Prudent BIOTECH
    • Prudent SMALL CAP
    • Prudent HEALTHCARE
  • MORE
    • FAQ
    • CONTACT US
  • LOGIN
    • LOGIN – BIOTECH
    • LOGIN – SMALL CAP
  • SIGN UP
    • SIGN UP – BIOTECH
    • RENEWAL – BIOTECH
is_archive

DNA Screening, Genomics, Prudent Healthcare
Healthcare Stocks
April 28, 2025

GeneDx: Strengthening Leadership In Genomic Diagnostics

GeneDx Holdings Corp. leverages genomic sequencing and data science for early diagnosis and treatment, focusing on pediatric outpatient and neonatal ICU settings.GeneDx will report Q1 2025 earnings on April 30,
by Chandra
Prudent Biotech

© 2024. All Rights Reserved.